Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLIER001 eplerenone in acute heart failure
jRCT2091220127Completed
- Sponsor
- Masafumi Kitakaze
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Acute Heart Failure (AHF) and heart failure with reduced ejection fraction (HFrEF) comparing Eplerenone 50 mg QD with Placebo 50 mg QD (2 arms). Primary endpoint: Primary composite endpoint at 6 months. Started Jun 2013; status: completed.
02
Drugs
eplerenone
03
Conditions
Acute Heart Failure (AHF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on jRCT2091220127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220127.